Rituximab as Maintenance Therapy for Difficult-to-Treat SLE
Biologics May Prevent Cardiovascular Events in RA Patients
Lenabasum for Diffuse Cutaneous Systemic Sclerosis
Biosimilar Prescribing Habits in the VA & Academic Settings
Biosimilars Are Slowly Climbing Toward Acceptance in Rheumatology
Are ANAs More Prevalent in the U.S. Now Than in the Past?
Researchers Discuss Viability of Rheumatology Education During the COVID‐19 Pandemic
9/11 Survivors at Increased Risk for Autoimmune Disease
Autoimmunity on the Rise in the U.S.
- 1
- 2
- 3
- …
- 8
- Next Page »